Literature DB >> 16869115

Testosterone replacement therapy for the treatment of neurological and neuropsychiatric disorders.

Stefan M Gold1, Rhonda R Voskuhl.   

Abstract

There is an accumulating body of evidence in the literature suggesting that testosterone may be neuroprotective and therefore have therapeutic value in the treatment of neurodegenerative diseases. In this article, the potential mechanisms of action of testosterone on the central nervous system are discussed, as well as the current evidence supporting the effect of testosterone on neurological impairment. Lower endogenous testosterone levels appear to be associated with some neurological disabilities. Conversely, a therapeutic benefit of exogenous testosterone supplementation on some cognitive abilities has been shown in pilot trials involving healthy elderly men as well as patients with multiple sclerosis and Alzheimer's disease. Further study of the therapeutic potential of testosterone is warranted in neurological and neuropsychiatric diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16869115

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  6 in total

1.  DHT inhibits the Aβ25-35-induced apoptosis by regulation of seladin-1, survivin, XIAP, bax, and bcl-xl expression through a rapid PI3-K/Akt signaling in C6 glial cell lines.

Authors:  Lelin Bing; Junfeng Wu; Jianfeng Zhang; Yinghui Chen; Zhen Hong; Hengbing Zu
Journal:  Neurochem Res       Date:  2014-10-28       Impact factor: 3.996

2.  Effect of endogenous androgens on 17beta-estradiol-mediated protection after spinal cord injury in male rats.

Authors:  Supatra Kachadroka; Alicia M Hall; Tracy L Niedzielko; Sukumal Chongthammakun; Candace L Floyd
Journal:  J Neurotrauma       Date:  2010-03       Impact factor: 5.269

3.  Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone.

Authors:  Stefan M Gold; Sara Chalifoux; Barbara S Giesser; Rhonda R Voskuhl
Journal:  J Neuroinflammation       Date:  2008-07-31       Impact factor: 8.322

4.  Hippocampal serotonin-2A receptor-immunoreactive neurons density increases after testosterone therapy in the gonadectomized male mice.

Authors:  Emsehgol Nikmahzar; Mehrdad Jahanshahi; Amir Ghaemi; Gholam Reza Naseri; Ali Reza Moharreri; Ahmad Ali Lotfinia
Journal:  Anat Cell Biol       Date:  2016-12-31

Review 5.  SeXX Matters in Multiple Sclerosis.

Authors:  Francesca Gilli; Krista D DiSano; Andrew R Pachner
Journal:  Front Neurol       Date:  2020-07-03       Impact factor: 4.003

6.  Testosterone Protects Mitochondrial Function and Regulates Neuroglobin Expression in Astrocytic Cells Exposed to Glucose Deprivation.

Authors:  Nicolas Toro-Urrego; Luis M Garcia-Segura; Valentina Echeverria; George E Barreto
Journal:  Front Aging Neurosci       Date:  2016-06-27       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.